Neuralink, Elon Musk’s startup licensed to test brain implants on humans

“It’s really an important step.” Neuralink, Elon Musk’s startup, thus defines the green light obtained by the Food and Drug Administration (Fda) to test its brain implants on humans. “This way our technology could one day help many people. Recruitment for clinical trials is not open yet,” the start-up said on Twitter.


Neuralink designs connected devices to be implanted in the brain to allow computers to communicate directly through thought. An aid above all for people who are paralyzed or suffering from neurological diseases, but the company wants to make these implants safe and reliable enough to be a choice for those who decide to equip their brain with computer power, obviously through a costly surgery of a few thousand dollars. As Elon Musk stated in 2020, these chips must enable humanity to achieve a “symbiosis with AI”. “We are now confident that Neuralink’s device is ready for humans, so the timing depends on the FDA approval process,” he said on Twitter in late November.

potential uses

The billionaire is not new to risky predictions, as demonstrated by the autonomy of Tesla electric cars. He estimated in July 2019 that Neuralink could perform its first tests on people in 2020. So far, coin-sized prototypes have only been implanted into animal skulls, with encouraging results. In fact, several monkeys are thus able to “play” video games or “type” words on a screen simply by following the movement of the cursor with their eyes. Other companies are working to control computers with thought, such as Synchron which announced in July 2022 that it had implanted the first brain-machine interface in the United States.